Neonatal hypoglycaemia and withdrawal symptoms after exposure in utero to valproate

AIMS To define, in a prospective study, the risk of hypoglycaemia—defined as blood glucose concentration

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Archives of disease in childhood. Fetal and neonatal edition 2000-09, Vol.83 (2), p.F124-F129
Hauptverfasser:	Ebbesen, Finn, Joergensen, Annemette, Hoseth, Eva, Kaad, Per-Henrik, Moeller, Margrethe, Holsteen, Vibeke, Rix, Mariane
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Amniocentesis Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Anticonvulsants - adverse effects Anticonvulsants - blood Babies Biological and medical sciences Blood blood glucose Carbamazepine - therapeutic use Drug dosages Drug Therapy, Combination Emergency and intensive care: neonates and children. Prematurity. Sudden death Epilepsy Epilepsy - drug therapy Female Glucose Humans hypoglycaemia Hypoglycemia - blood Hypoglycemia - chemically induced Infant, Newborn Infants Intensive care medicine Liver Male Medical sciences Neonatal Abstinence Syndrome - etiology Original Oxidation Pregnancy Pregnancy Complications - drug therapy Pregnancy Trimester, Third Prenatal Exposure Delayed Effects Prospective Studies Risk Factors Ultrasonic imaging Umbilical cord valproate Valproic Acid - adverse effects Valproic Acid - blood withdrawal symptoms
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	AIMS To define, in a prospective study, the risk of hypoglycaemia—defined as blood glucose concentration
ISSN:	1359-2998 1468-2052
DOI:	10.1136/fn.83.2.F124